£145
Roche SARS‐CoV‐2 (COVID-19) Rapid Nasal Lateral Flow Diagnostic Antigen Test (Box of 25 Tests)
RocheIn comparison to the existing Roche SARS-CoV-2 Rapid Antigen Test, the SARS-CoV-2 Rapid Antigen Test Nasal collects the sample from the front area of the nose instead of the nasopharynx, resulting in a simplified, more comfortable and faster testing procedure.
Description
In comparison to the existing Roche SARS-CoV-2 Rapid Antigen Test, the SARS-CoV-2 Rapid Antigen Test Nasal collects the sample from the front area of the nose instead of the nasopharynx, resulting in a simplified, more comfortable and faster testing procedure.
Included In Each Box (25 Packs Per Box)
Each kit contains 25 individually packaged, ready to use tests containing all equipment needed to perform a test, and comprises of:
▪ Test device – individual foil wrapped with desiccant
▪ Extraction buffer tube and buffer tube rack
▪ Nozzle cap
▪ Sterile swab
▪ Positive and negative controls
▪ Instructions for use and Quick Reference Guide
Technical Specification:
Test Sample Type: Nasal
Detailed Technical Information –
SARS-CoV-2 Rapid Antigen Test characteristics
▪ Assay format: Lateral flow test / immunochromatographic
▪ Instrument: No
▪ Testing time: 15-30 minutes
▪ Specificity: 98.6%
▪ Sensitivity: 90.6% (Ct value ≤ 30)
▪ Antigen: N
▪ Sample material: Nasal Swab
▪ Reagents: mAb anti-COVID19 antibody, mAb anti-Chicken IgY, mAb anti-COVID-19 antibody‑gold conjugate, Purified chicken IgY‑gold conjugate
Tested against new variants
The Roche Antigen Tests have been checked against the new Indian variant including B.1.617.1 and B.1.617.2 and are suitable for detecting these SARS-CoV-2 variants. The tests have also been checked against Kent B.1.1.7 lineage, South Africa B.1.351 and Brazil P.1 lineage.
Strictly for professional use only